Literature DB >> 27966564

Habitual dietary phosphorus intake and urinary excretion in chronic kidney disease patients: a 3-day observational study.

L Salomo1,2, A-L Kamper1, G M Poulsen1, S K Poulsen2, A Astrup2, M Rix1.   

Abstract

Hyperphosphatemia in chronic kidney disease (CKD) is associated with vascular calcification, cardiovascular morbidity and mortality. The aim of this study was to estimate the daily dietary phosphorus intake compared with recommendations in CKD patients and to evaluate the reproducibility of the 24-h urinary phosphorus excretion. Twenty CKD patients stage 3-4 from the outpatient clinic, collected 24-h urine and kept dietary records for 3 consecutive days. The mean daily phosphorus intake was 1367±499, 1642±815 and 1426±706 mg/day, respectively (P=0.57). The mean urinary phosphorus excretion was 914±465, 954±414 and 994±479 mg/day, respectively (P=0.21). In this population of CKD patients stage 3-4 the daily phosphorus intake was above the recommended. Twenty-four-hour urinary phosphorus excretion was reproducible and the data indicate that a single 24-h urine collection is sufficient to estimate the individual phosphorus excretion.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27966564     DOI: 10.1038/ejcn.2016.247

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  9 in total

1.  Phosphorus additives in food and their effect in dialysis patients.

Authors:  Jaime Uribarri
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 8.237

2.  Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients.

Authors:  Omar Benini; Claudia D'Alessandro; Daniela Gianfaldoni; Adamasco Cupisti
Journal:  J Ren Nutr       Date:  2010-11-05       Impact factor: 3.655

3.  Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method.

Authors:  S B Heymsfield; C Arteaga; C McManus; J Smith; S Moffitt
Journal:  Am J Clin Nutr       Date:  1983-03       Impact factor: 7.045

4.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 5.  Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Lisa Gutekunst; Rajnish Mehrotra; Csaba P Kovesdy; Rachelle Bross; Christian S Shinaberger; Nazanin Noori; Raimund Hirschberg; Debbie Benner; Allen R Nissenson; Joel D Kopple
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 8.237

6.  Regulation of fibroblast growth factor-23 in chronic kidney disease.

Authors:  Per-Anton Westerberg; Torbjörn Linde; Björn Wikström; Osten Ljunggren; Mats Stridsberg; Tobias E Larsson
Journal:  Nephrol Dial Transplant       Date:  2007-06-13       Impact factor: 5.992

7.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors: 
Journal:  Kidney Int Suppl       Date:  2009-08       Impact factor: 10.545

8.  Estimate of dietary phosphorus intake using 24-h urine collection.

Authors:  Yuuka Morimoto; Masae Sakuma; Hiroyuki Ohta; Akitsu Suzuki; Asami Matsushita; Minako Umeda; Makoto Ishikawa; Yutaka Taketani; Eiji Takeda; Hidekazu Arai
Journal:  J Clin Biochem Nutr       Date:  2014-06-14       Impact factor: 3.114

Review 9.  North American experience with Low protein diet for Non-dialysis-dependent chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Linda W Moore; Amanda R Tortorici; Jason A Chou; David E St-Jules; Arianna Aoun; Vanessa Rojas-Bautista; Annelle K Tschida; Connie M Rhee; Anuja A Shah; Susan Crowley; Joseph A Vassalotti; Csaba P Kovesdy
Journal:  BMC Nephrol       Date:  2016-07-19       Impact factor: 2.388

  9 in total
  2 in total

1.  Effect of Dietary Phosphorous Restriction on Fibroblast Growth 2 Factor-23 and sKlotho Levels in Patients with Stages 1-2 Chronic Kidney Disease.

Authors:  Anita Saxena; Trisha Sachan; Amit Gupta; Vishwas Kapoor
Journal:  Nutrients       Date:  2022-08-12       Impact factor: 6.706

2.  Randomized Trial of Acute Changes in Plasma Phosphate After Phosphorus-Standardized Meals in Peritoneal Dialysis.

Authors:  Martin Thorbjørn Lundin; Iain Bressendorff; Bent Kristensen; Niklas Rye Jørgensen; Rizwan Butt; Ditte Hansen
Journal:  Kidney Int Rep       Date:  2021-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.